Ventas [VTR] vs American Healthcare [AHR] Detailed Stock Comparison
Ventas
NYSE
Loading...
American Healthcare
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ventas wins in 11 metrics, American Healthcare wins in 8 metrics, with 0 ties. Ventas appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ventas | American Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 194.30 | -140.93 | American Healthcare |
| Price-to-Book Ratio | 2.52 | 2.78 | Ventas |
| Debt-to-Equity Ratio | 108.90 | 69.74 | American Healthcare |
| PEG Ratio | 400.75 | -0.28 | American Healthcare |
| EV/EBITDA | 21.81 | 23.56 | Ventas |
| Profit Margin (TTM) | 2.82% | -1.53% | Ventas |
| Operating Margin (TTM) | 14.15% | 8.33% | Ventas |
| EBITDA Margin (TTM) | 14.15% | 8.33% | Ventas |
| Return on Equity | 1.38% | -1.41% | Ventas |
| Return on Assets (TTM) | 1.92% | 2.12% | American Healthcare |
| Free Cash Flow (TTM) | $725.78M | $84.15M | Ventas |
| Dividend Yield | 2.92% | 2.80% | Ventas |
| 1-Year Return | 16.01% | 102.19% | American Healthcare |
| Price-to-Sales Ratio (TTM) | 5.72 | 3.22 | American Healthcare |
| Enterprise Value | $42.06B | $8.52B | Ventas |
| EV/Revenue Ratio | 8.32 | 3.98 | American Healthcare |
| Gross Profit Margin (TTM) | 42.15% | 21.42% | Ventas |
| Revenue per Share (TTM) | $12 | $14 | American Healthcare |
| Earnings per Share (Diluted) | $0.33 | $-0.25 | Ventas |
| Beta (Stock Volatility) | 0.97 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ventas vs American Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ventas | -0.09% | 2.35% | 4.03% | 8.65% | 4.60% | 19.25% |
| American Healthcare | 1.80% | 5.17% | 12.23% | 24.32% | 55.55% | 53.08% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ventas | 16.01% | 43.11% | 61.80% | 21.93% | 19.56% | 99.31% |
| American Healthcare | 102.19% | 223.78% | 223.78% | 223.78% | 223.78% | 223.78% |
Performance & Financial Health Analysis: Ventas vs American Healthcare
| Metric | VTR | AHR |
|---|---|---|
| Market Information | ||
| Market Cap | $28.94B | $6.89B |
| Market Cap Category | Large cap | Mid cap |
| 10 Day Avg. Volume | 2,946,590 | 1,634,670 |
| 90 Day Avg. Volume | 2,823,467 | 1,261,497 |
| Last Close | $69.12 | $42.48 |
| 52 Week Range | $56.68 - $71.36 | $19.47 - $42.54 |
| % from 52W High | -3.14% | -0.14% |
| All-Time High | $96.05 (May 20, 2013) | $42.54 (Aug 21, 2025) |
| % from All-Time High | -28.04% | -0.14% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.08% |
| Quarterly Earnings Growth | 0.13% | 4.01% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | -0.02% |
| Operating Margin (TTM) | 0.14% | 0.08% |
| Return on Equity (TTM) | 0.01% | -0.01% |
| Debt to Equity (MRQ) | 108.90 | 69.74 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $25.43 | $14.71 |
| Cash per Share (MRQ) | $0.40 | $0.80 |
| Operating Cash Flow (TTM) | $1.38B | $254.73M |
| Levered Free Cash Flow (TTM) | $869.68M | $164.55M |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.92% | 2.80% |
| Last 12-Month Dividend | $1.83 | $1.00 |
Valuation & Enterprise Metrics Analysis: Ventas vs American Healthcare
| Metric | VTR | AHR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 194.30 | -140.93 |
| Forward P/E | 400.75 | 215.16 |
| PEG Ratio | 400.75 | -0.28 |
| Price to Sales (TTM) | 5.72 | 3.22 |
| Price to Book (MRQ) | 2.52 | 2.78 |
| Market Capitalization | ||
| Market Capitalization | $28.94B | $6.89B |
| Enterprise Value | $42.06B | $8.52B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.32 | 3.98 |
| Enterprise to EBITDA | 21.81 | 23.56 |
| Risk & Other Metrics | ||
| Beta | 0.97 | N/A |
| Book Value per Share (MRQ) | $25.43 | $14.71 |
Financial Statements Comparison: Ventas vs American Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VTR | AHR |
|---|---|---|
| Revenue/Sales | $1.36B | $540.60M |
| Cost of Goods Sold | $785.71M | $432.42M |
| Gross Profit | $572.37M | $108.18M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $197.69M | $40.27M |
| EBITDA | $521.86M | $90.88M |
| Pre-Tax Income | $37.80M | $-6.24M |
| Income Tax | $-10.56M | $604,000 |
| Net Income (Profit) | $48.36M | $-6.84M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VTR | AHR |
|---|---|---|
| Cash & Equivalents | $897.85M | $86.06M |
| Total Current Assets | $1.35B | $370.05M |
| Total Current Liabilities | $1.30B | $914.84M |
| Long-Term Debt | $13.73B | $1.19B |
| Total Shareholders Equity | $10.83B | $2.30B |
| Retained Earnings | N/A | $-1.50B |
| Property, Plant & Equipment | N/A | $153.35M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VTR | AHR |
|---|---|---|
| Operating Cash Flow | $352.04M | $36.94M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $203.39M | $39.44M |
| Debt Repayment | $-88.55M | $-92.21M |
| Common Stock Repurchase | N/A | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | VTR | AHR |
|---|---|---|
| Shares Short | 13.72M | 4.33M |
| Short Ratio | 4.13 | 3.84 |
| Short % of Float | 0.04% | 0.03% |
| Average Daily Volume (10 Day) | 2,946,590 | 1,634,670 |
| Average Daily Volume (90 Day) | 2,823,467 | 1,261,497 |
| Shares Outstanding | 437.08M | 157.45M |
| Float Shares | 448.90M | 167.10M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 1.00% | 0.98% |
Dividend Analysis & Yield Comparison: Ventas vs American Healthcare
| Metric | VTR | AHR |
|---|---|---|
| Last 12-Month Dividend | $1.83 | $1.00 |
| Last 12-Month Dividend Yield | 2.92% | 2.80% |
| 3-Year Avg Annual Dividend | $1.66 | $0.42 |
| 3-Year Avg Dividend Yield | 0.91% | 1.23% |
| 3-Year Total Dividends | $4.98 | $1.25 |
| Ex-Dividend Date | Mar 31, 2025 | Mar 31, 2025 |